Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Kyverna Therapeutics says it will present updated trial data in stiff person syndrome and progressive multiple sclerosis at MSToronto2026, including one-year KYSA-8 results from its KYSA-8 registrational trial and Phase 1 investigator-initiated trial data.
Kyverna flagged new one-year results from its KYSA-8 registrational trial of miv-cel in stiff person syndrome, to be presented at MSToronto2026 on Oct. 21, 2026. Updated Phase 1 investigator-initiated progressive multiple sclerosis findings will be presented Oct. 23, 2026. Management said it is working to complete a BL